Ki-1-positive anaplastic large-cell lymphoma (ALCL) is an uncommon neoplasm which may present with extranodal as well as nodal disease. By definition, the tumor cells are immunoreactive for Ki-1 or Ber-H2 antigen (CD30). There have been few published cytologic descriptions of this lymphoma, or of its detection in extranodal sites. We describe the cytologic findings in five cases of extranodal Ki-1 lymphoma. Cytologic findings in all five cases were similar and consisted of a heterogeneous population of lymphocytes and bizarre, pleomorphic tumor cells. These cells were characterized by generous amounts of vacuolated, basophilic cytoplasm, eccentric, multilobulated nuclei with some showing "wreath-like" configurations. Some nuclei contained huge nucleoli simulating Reed-Sternberg cells. All cases showed the characteristic surface membrane and cytoplasmic paranuclear dot-like staining for CD30. Our findings indicate that fine-needle aspiration and exfoliative cytology have a useful role in the diagnosis of Ki-1 ALCL in extranodal sites. Furthermore, effusions containing anaplastic cells suspicious for lymphoma, particularly in AIDS patients, should be immunostained with antibodies to CD30.

Download full-text PDF

Source
http://dx.doi.org/10.1002/(SICI)1097-0339(199603)14:2<155::AID-DC10>3.0.CO;2-LDOI Listing

Publication Analysis

Top Keywords

extranodal ki-1
8
tumor cells
8
extranodal sites
8
cytologic findings
8
findings cases
8
lymphoma
5
cells
5
cytology extranodal
4
ki-1
4
ki-1 anaplastic
4

Similar Publications

Genomic analysis reveals molecular characterization of CD30 and CD30 extranodal natural killer/T-cell lymphomas (ENKTLs).

Hum Pathol

October 2024

Department of Pathology, School of Basic Medical Sciences and Qilu Hospital, Shandong University, Jinan, China. Electronic address:

Article Synopsis
  • Extranodal natural killer/T-cell lymphoma (ENKTL) is common in Asians, but its molecular characteristics are not well understood; this study focuses on CD30 expression and genetics of samples.
  • CD30 was found to be positive in approximately 55.74% of ENKTLs, and significant mutations were noted in various genes related to cell function and cancer progression, highlighting the involved pathways.
  • The study discovered higher BCL10 expression in ENKTL compared to normal tissues, suggesting that BCL10 inhibitors may offer a new treatment option for this type of lymphoma.
View Article and Find Full Text PDF

[Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

April 2024

Department of Hematology, The Affiliated Hospital of Nanjing Medical University, Changzhou No.2 People's Hospital, Changzhou 213000, Jiangsu Province, China.E-mail:

Objective: To investigate the expression and clinical significance of CD30 in patients with diffuse large B-cell lymphoma (DLBCL).

Methods: A retrospective analysis was conducted on 124 cases of primary DLBCL diagnosed at Changzhou Second People's Hospital Affiliated with Nanjing Medical University from January 2018 to July 2020. The expression of CD30 in patients with DLBCL was detected by immunohistochemical method, and the clinicopathological characteristics were analyzed and compared between CD30 and CD30 groups.

View Article and Find Full Text PDF

Background: Chimeric antigen receptor (CAR) T cells targeting CD30 are safe and have promising activity when preceded by lymphodepleting chemotherapy. We aimed to determine the safety of anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation (HSCT) in patients with CD30 lymphoma at high risk of relapse.

Methods: This phase 1 dose-escalation study was performed at two sites in the USA.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed CD30 expression in 82 patients with newly diagnosed extranodal natural killer/T-cell lymphoma (ENKTL) and found that high levels of CD30 (over 40%) were linked to better overall survival compared to low or negative levels.
  • Patients with positive CD30 expression showed a significant correlation with Epstein-Barr virus status and were identified as having a better prognosis, alongside other factors like advanced CA ENKTL stage.
  • Results suggest that CD30 expression can be used for patient stratification in clinical settings, helping to inform treatment and survival expectations.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!